|
|
|
市場調查報告書
葡萄糖耐受不良相關全球臨床實驗回顧:2011年下半年
Glucose Intolerance Global Clinical Trials Review, H2, 2011
| 出版商 |
GlobalData |
| 出版日期 |
2011年09月 |
商品編碼 |
217229 |
| 內容資訊 |
英文 Pages: 78 |
| 價格 |
|
|
葡萄糖耐受不良相關全球臨床實驗回顧:2011年下半年 是由出版商GlobalData在2011年09月所出版的。
這份英文市場調查報告書包含Pages: 78 價格從美金1000起跳。
葡萄糖耐受不良是糖尿病的預備軍，亦可稱之為血糖值未超過正常值的糖尿病。這跟胰島素抗性有關，並會提高心血管疾病的風險。20歲∼79歲的全球葡萄糖耐受不良者（IGT）有3億4400萬人，佔總人口的7.9%，預測到2030年會增加到4億7200萬人，佔總人口的8.4%。
本報告提供全球2011年下半年的葡萄糖耐受不良相關臨床實驗資料調查，從各地區，各階段進行分析，介紹正在開發的藥物概要，以及1982年開始到2011年9月的現在70種登記藥物相關資料，為您概述為以下內容。
目錄
簡介
各地區臨床實驗
- 各國家臨床實驗
- 金磚四國
- G7各國
- 各臨床實驗狀況G7臨床實驗
- E7各國
- 各臨床實驗狀況E7臨床實驗
- 各階段臨床實驗
- 未完成臨床實驗
- 一定期間內募集的實驗對象
- 主要的臨床實驗要求者
- 藥物比較
- 臨床實驗簡介
- 主要企業
- Merck & Co., Inc
- Novartis
- 鹽野義製藥
- 大學·機關·醫院
- Yale University
- Seattle Institute for Biomedical and Clinical Research
- Hadassah Medical Organization
- University of Oslo
- The National Institute of Diavetes and Digestive Kidney Disease
- University of Leipzig
- University of Sherbrooke
- 東京大學
- Northwestern University
- Hillel Yaffe Medical Center
- University of California, Los Angeles
- Gentofte University Hospital
- University of Copenhagen
- Tel-Aviv Sourasky Medical Center
- University Hospital Tubingen
- University of Missouri
- Emory University
- University of Oxford
- University of Miami
- Lawson Health Research Institute
5個主要的臨床實驗簡介
附錄
圖表
Abstract
Summary
GlobalData's clinical trial report, "Glucose Intolerance Global Clinical Trials Review, H2, 2011" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucose Intolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
- Table of Contents
- List of Tables
- List of Figures
- Introduction
- Glucose Intolerance
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Glucose Intolerance
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Glucose Intolerance Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Merck & Co., Inc.
- Clinical Trial Overview of Merck & Co., Inc.
- Novartis AG
- Clinical Trial Overview of Novartis AG
- Shionogi & Co., Ltd.
- Clinical Trial Overview of Shionogi & Co., Ltd.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Yale University
- Clinical Trial Overview of Yale University
- Seattle Institute for Biomedical and Clinical Research
- Clinical Trial Overview of Seattle Institute for Biomedical and Clinical Research
- Hadassah Medical Organization
- Clinical Trial Overview of Hadassah Medical Organization
- University of Oslo
- Clinical Trial Overview of University of Oslo
- The National Institute of Diabetes and Digestive and Kidney Diseases
- Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
- University of Leipzig
- Clinical Trial Overview of University of Leipzig
- University of Sherbrooke
- Clinical Trial Overview of University of Sherbrooke
- The University of Tokyo
- Clinical Trial Overview of The University of Tokyo
- Northwestern University
- Clinical Trial Overview of Northwestern University
- Hillel Yaffe Medical Center
- Clinical Trial Overview of Hillel Yaffe Medical Center
- University of California, Los Angeles
- Clinical Trial Overview of University of California, Los Angeles
- Gentofte University Hospital
- Clinical Trial Overview of Gentofte University Hospital
- University of Copenhagen
- Clinical Trial Overview of University of Copenhagen
- Tel-Aviv Sourasky Medical Center
- Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
- University Hospital Tubingen
- Clinical Trial Overview of University Hospital Tubingen
- University of Missouri
- Clinical Trial Overview of University of Missouri
- Emory University
- Clinical Trial Overview of Emory University
- University of Oxford
- Clinical Trial Overview of University of Oxford
- University of Miami
- Clinical Trial Overview of University of Miami
- Lawson Health Research Institute
- Clinical Trial Overview of Lawson Health Research Institute
- Five Key Clinical Profiles
Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
List of Tables
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Zone, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, BRIC Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, G7 Countries, 2011*
- Glucose Intolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, E7 Countries, 2011*
- Glucose Intolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Phase, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Glucose Intolerance Therapeutics Market, Global, Terminated Clinical Trials, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Institute for Biomedical and Clinical Research, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oslo, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sherbrooke, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillel Yaffe Medical Center, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Gentofte University Hospital, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Copenhagen, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2011*
- Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2011*
List of Figures
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
- Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011*
- Glucose Intolerance Therapeutics Clinical Trials, BRIC Countries (%), 2011*
- Glucose Intolerance Therapeutics Clinical Trials, G7 Countries (%), 2011*
- Glucose Intolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, E7 Countries (%), 2011*
- Glucose Intolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
- Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
- Glucose Intolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
- GlobalData Methodology
|
 |
